Blood Tests for Diagnosing Hemochromatosis
Begin with simultaneous measurement of transferrin saturation and serum ferritin—these two tests together form the essential first-line diagnostic approach for hereditary hemochromatosis. 1, 2, 3
Initial Screening Tests
Transferrin Saturation (Primary Screening Test)
- Transferrin saturation ≥45% is the most sensitive early marker and the primary threshold that triggers further evaluation for iron overload 1, 2, 3
- Calculate as: (serum iron ÷ total iron binding capacity) × 100 1, 2
- This test has 84% sensitivity in men and 73% sensitivity in women for detecting C282Y homozygosity 4
- Never interpret serum iron alone—always calculate transferrin saturation 4
Serum Ferritin (Concurrent Measurement Required)
- Must be measured simultaneously with transferrin saturation for optimal diagnostic accuracy 1, 2, 3
- Diagnostic thresholds: >300 μg/L in men or >200 μg/L in women 1, 2, 3, 5
- Ferritin >1,000 μg/L predicts cirrhosis risk, especially when combined with elevated liver enzymes and platelet count <200,000/μL 1, 2, 4
- Critical caveat: Ferritin is an acute-phase reactant that rises with inflammation, liver disease, malignancy, and tissue necrosis independent of iron stores 1, 2, 4, 6
Diagnostic Algorithm Based on Initial Results
If Transferrin Saturation ≥45% AND Elevated Ferritin:
- Proceed immediately to HFE genetic testing for C282Y and H63D mutations 1, 2, 3, 7, 5
- C282Y homozygosity confirms HFE-related hemochromatosis and accounts for 85-90% of clinically affected patients 2, 3, 8, 7, 5
- C282Y/H63D compound heterozygosity also confirms diagnosis 2, 3, 7
If Transferrin Saturation <45%:
- Iron overload is excluded with >90% certainty 4
- Elevated ferritin in this context reflects secondary causes: chronic alcohol consumption, inflammation, cell necrosis, tumors, or metabolic syndrome/NAFLD—not hemochromatosis 1, 4, 6
- Do not order HFE genetic testing when transferrin saturation is <45% 4, 6
Additional Laboratory Tests for Disease Severity Assessment
Liver Function Tests
- Obtain ALT, AST, and platelet count to assess for cirrhosis risk 1, 2, 3
- The combination of ferritin >1,000 μg/L + elevated aminotransferases + platelet count <200,000/μL predicts cirrhosis in ~80% of C282Y homozygotes 1, 2, 4, 3
Complete Blood Count
- Check CBC with differential to exclude anemia and red cell disorders 3
- Platelet count <200,000/μL suggests advanced liver disease 1, 2, 4
Inflammatory Markers (When Ferritin is Elevated but TS <45%)
- Measure CRP and ESR to identify inflammatory causes of secondary hyperferritinemia 4
When to Consider Liver Biopsy
Liver biopsy is indicated when:
- Ferritin >1,000 μg/L with elevated liver enzymes (ALT/AST) 1, 2, 4, 3
- Ferritin >1,000 μg/L with platelet count <200,000/μL 1, 2, 4
- Age >40 years in C282Y homozygotes with ferritin >1,000 μg/L 1, 2, 3
- Hepatomegaly on examination 1, 3
Liver biopsy is NOT needed when:
- Ferritin <1,000 μg/L (94% negative predictive value for advanced fibrosis) 1, 4
- Normal liver enzymes and age <40 years in confirmed C282Y homozygotes 4
Alternative/Supplementary Tests
MRI for Hepatic Iron Quantification
- Use MRI to quantify hepatic iron concentration when the cause of hyperferritinemia is unclear despite biochemical testing 2, 4, 3
- Particularly useful when transferrin saturation is ≥45% 4
Unsaturated Iron Binding Capacity (UIBC)
- UIBC has equal reliability to transferrin saturation for detecting hemochromatosis 9
- Optimum threshold: 143 μg/dL (25.6 μmol/L) with sensitivity 0.91 and specificity 0.95 9
- Can be used as an inexpensive alternative to transferrin saturation 9
Critical Pitfalls to Avoid
- Never use ferritin alone to diagnose iron overload—transferrin saturation must be assessed concurrently 1, 2, 4, 6
- Do not assume iron overload when transferrin saturation <45%—over 90% of elevated ferritin cases with low transferrin saturation are NOT due to iron overload 1, 4, 6
- Do not order genetic testing when transferrin saturation <45%—this leads to misdiagnosis and unnecessary treatment 4, 6
- Do not overlook liver biopsy in patients with ferritin >1,000 μg/L and abnormal liver tests 1, 4
- Recognize that normal transferrin saturation occurs in up to 33% of C282Y homozygotes due to biological variability—repeat testing may be needed 4
Family Screening Protocol
- All first-degree relatives of confirmed hemochromatosis patients should undergo both HFE genetic testing AND simultaneous phenotypic screening (transferrin saturation and ferritin) 1, 3, 8, 5
- Siblings have 33% probability of C282Y homozygosity 3
- Genetic testing should be offered after 18 years of age 5